These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7114830)

  • 21. Serum and urine concentrations of rifampicin administered by intravenous infusion in man.
    Acocella G; Bonollo L; Mainardi M; Margaroli P; Tenconi LT
    Arzneimittelforschung; 1977; 27(6):1221-6. PubMed ID: 578447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue distribution and deposition of clofazimine in rat following subchronic treatment with or without rifampicin.
    Mamidi NV; Rajasekhar A; Prabhakar MC; Krishna DR
    Arzneimittelforschung; 1995 Sep; 45(9):1029-31. PubMed ID: 7488306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of probenecid on serum rifampicin levels.
    Pankaj R; Lal S; Rao RS
    Indian J Lepr; 1985; 57(2):329-33. PubMed ID: 4078358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NTP technical report on toxicity studies of urethane in drinking water and urethane in 5% ethanol administered to F344/N rats and B6C3F1 mice.
    Chan PC
    Toxic Rep Ser; 1996 Mar; (52):1-91, A1-9, B1-9 passim. PubMed ID: 11803705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability of rifampicin caplets (600 mg and 450 mg) in healthy Indonesian subjects.
    Ganiswarna SG; Wilmana PF; Setiabudy R; Ringoringo VS
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):60-4. PubMed ID: 3957493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution profile of 2,5-dimethoxy-4-bromoamphetamine (DOB) in rats after oral and subcutaneous doses.
    Beránková K; Szkutová M; Balíková M
    Forensic Sci Int; 2007 Aug; 170(2-3):94-9. PubMed ID: 17629428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacokinetics of rifampicin.
    Acocella G
    Clin Pharmacokinet; 1978; 3(2):108-27. PubMed ID: 346286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and experimental rifampicin passage through the hemato-encephalic barrier and its effectiveness in treating meningococcal infections].
    Ivanov KS; Verovaia AV; Dergunova GA; Duiunov VM; Popova NN
    Antibiotiki; 1981 May; 26(5):383-8. PubMed ID: 7259147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA adduct formation and T lymphocyte mutation induction in F344 rats implanted with tumorigenic doses of 1,6-dinitropyrene.
    Beland FA
    Res Rep Health Eff Inst; 1995 Oct; (72):1-27; discussion 29-39. PubMed ID: 11381742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of radio-labeled N-Acetyl-L-Cysteine in Sprague-Dawley rats and its effect on glutathione metabolism following single and repeat dosing by oral gavage.
    Arfsten DP; Johnson EW; Wilfong ER; Jung AE; Bobb AJ
    Cutan Ocul Toxicol; 2007; 26(2):113-34. PubMed ID: 17612979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sisomicin pharmacokinetics in rat tissues in single and long-term administration].
    Umnova LV; Koroleva VG; Goncharskaia TIa; Firsov AA; Fomina IP
    Antibiotiki; 1981 Aug; 26(8):612-7. PubMed ID: 7294752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of a rifampicin-trimethoprim combination.
    Buniva G; Palminteri R; Berti M
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):256-9. PubMed ID: 468449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influence of carbachol on intestinal dysfunction after traumatic or burn injury].
    Cao WH; Chai JK; Hu S; Yang HM; Sun TJ; Zou XF; Sheng ZY
    Zhonghua Shao Shang Za Zhi; 2006 Jun; 22(3):168-71. PubMed ID: 16964640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTP Toxicology and Carcinogenesis Studies of Ozone (CAS No. 10028-15-6) and Ozone/NNK (CAS No. 10028-15-6/ 64091-91-4) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Oct; 440():1-314. PubMed ID: 12595923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diffusion of rifampicin into spongy and compact bone tissue during total hip prosthesis operation].
    Sirot J; Prive L; Lopitaux R; Glanddier Y
    Pathol Biol (Paris); 1983 May; 31(5):438-41. PubMed ID: 6353337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.